ArticleOncotarget2016

Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment.

Wei Bin Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.